These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16413842)

  • 21. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.
    Jesam C; Salvatierra AM; Schwartz JL; Fuentes A; Croxatto HB
    Contraception; 2014 Aug; 90(2):168-73. PubMed ID: 24909636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-cycle treatment in oral contraception].
    Kuhl H; Birkhäuser M; Mueck A; Neulen J; Thaler C; Kiesel L; Braendle W
    Ther Umsch; 2009 Feb; 66(2):101-8. PubMed ID: 19180430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faculty statement from the CEU on a new publication: WHO Selected Practice Recommendations for Contraceptive Use Update. Missed pills: new recommendations.
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2005 Apr; 31(2):153-5. PubMed ID: 15921560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
    Westhoff C; Osborne LM; Schafer JE; Morroni C
    Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use.
    Herzog AG; Blum AS; Farina EL; Maestri XE; Newman J; Garcia E; Krishnamurthy KB; Hoch DB; Replansky S; Fowler KM; Smithson SD; Dworetzky BA; Bromfield EB
    Neurology; 2009 Mar; 72(10):911-4. PubMed ID: 19273825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial.
    Lundin C; Danielsson KG; Bixo M; Moby L; Bengtsdotter H; Jawad I; Marions L; Brynhildsen J; Malmborg A; Lindh I; Sundström Poromaa I
    Psychoneuroendocrinology; 2017 Feb; 76():135-143. PubMed ID: 27923181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for eliminating the hormone-free interval in modern oral contraceptives.
    London A; Jensen JT
    Int J Gynaecol Obstet; 2016 Jul; 134(1):8-12. PubMed ID: 27067074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choosing the Right Oral Contraceptive Pill for Teens.
    Powell A
    Pediatr Clin North Am; 2017 Apr; 64(2):343-358. PubMed ID: 28292450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choices: "the pill" combined oral contraceptive.
    Contracept Technol Update; 2000 Sep; 21(9 Suppl):1-2. PubMed ID: 12296182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives.
    Steward R; Melamed A; Granat A; Mishell DR
    Contraception; 2012 Dec; 86(6):710-5. PubMed ID: 22682723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The triphasics: insights for effective clinical use.
    Youngkin EQ; Miller LG
    Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations.
    Stanczyk FZ; Archer DF
    Contraception; 2014 Apr; 89(4):242-52. PubMed ID: 24485094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.
    Richman S
    Obstet Gynecol; 2010 Apr; 115(4):866-867. PubMed ID: 20308851
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and biological justifications for the use of Triella].
    McGuire JL; Pasquale SA; Castaigne JP
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contraception and the big "C".
    Chandran R
    Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: a double-blind, randomised, dose-finding pilot study.
    Chabbert-Buffet N; Chassard D; Ochsenbein E; Thomas JL; Christin-Maitre S
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):76-84. PubMed ID: 21332383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovulation incidence with oral contraceptives: a literature review.
    Milsom I; Korver T
    J Fam Plann Reprod Health Care; 2008 Oct; 34(4):237-46. PubMed ID: 18854069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combined oral contraceptive pill -- recent developments, risks and benefits.
    Dragoman MV
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):825-34. PubMed ID: 25028259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female sexual dysfunction with combined oral contraceptive use.
    Lee JJ; Tan TC; Ang SB
    Singapore Med J; 2017 Jun; 58(6):285-288. PubMed ID: 28642961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.